Research map: Case Report: Sickle cell anemia with complex alloimmunization

Back to the article

Papers in this map

  1. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy–negative individuals · Christophe Tournamille · 1995 · 760 citations · Cited by this paper
  2. The role of necroptosis as a possible therapeutic target in multiple myeloma: the emerging roles of necroptosis · 2026 · Related
  3. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support · Stella T. Chou · 2020 · 499 citations · Cited by this paper
  4. Case Report: A converging pathology: Chediak–Higashi syndrome and IEI-associated lymphoproliferative disease · 2026 · Related
  5. Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases · Erwin W. Gelfand · 2012 · 493 citations · Cited by this paper
  6. Soluble immune checkpoint landscape in sickle cell disease links systemic inflammation, autoimmunity, and pain · 2025 · Related
  7. Sickle Cell Disease · Patricia L. Kavanagh · 2022 · 484 citations · Cited by this paper
  8. Advances in Chimeric Antigen Receptor T-cell therapy for hematologic malignancies and autoimmune conditions: a review of the 2024 American Society of Hematology Annual Meeting · 2025 · Related
  9. The global distribution of the Duffy blood group · Rosalind E. Howes · 2011 · 418 citations · Cited by this paper
  10. Portuguese real-world experience with ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma · 2025 · Related
  11. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. · Stephen C. Peiper · 1995 · 311 citations · Cited by this paper
  12. Real-world data of azacitidine for relapsed/refractory nodal T-follicular helper cell lymphoma in 11 patients · 2025 · Related
  13. Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages · Sietse Quirijn Nagelkerke · 2014 · 109 citations · Cited by this paper
  14. Case Report: two cases of idiopathic plasmacytic lymphadenopathy subtype of idiopathic multicentric Castleman disease with xanthelasma palpebrum from a Canadian center · 2026 · Related
  15. Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias · Hanny T. Al-Samkari · 2021 · 76 citations · Cited by this paper
  16. Complications and treatment patterns in patients with non-transfusion-dependent α- and β-thalassemia compared with matched controls: a retrospective observational study using administrative claims data in the United States · 2026 · Related
  17. Alloimmunization and hyperhemolysis in sickle cell disease · France Pirenne · 2023 · 38 citations · Cited by this paper
  18. Associations with the quality of life of adult family members or partners (informal carers) of people with leukaemia: results from a cross-sectional online global survey · 2026 · Related
  19. Recurrent acute hemolytic transfusion reactions by antibodies against Do a antigens, not detected by cross‐matching · Ruben Baumgarten · 2005 · 17 citations · Cited by this paper
  20. Understanding therapy-related AML: genetic insights and emerging strategies for high-risk patients · 2025 · Related
  21. Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy · Elizabeth F. Stone · 2020 · 14 citations · Cited by this paper
  22. Recombinant erythropoietin as alternative to red cell transfusion in sickle cell disease · Francisco A. Ferreira · 2019 · 10 citations · Cited by this paper
  23. Disease-modifying treatments for primary autoimmune haemolytic anaemia · Anthony P. Y. Liu · 2021 · 6 citations · Cited by this paper
  24. Alloimmunization against Fy3 is a serious threat in the era of cell therapy · Baptiste Lemaire · 2022 · 4 citations · Cited by this paper
  25. The prevalence of selected clinically significant red blood cell antigens among Australian blood donors · Rena Hirani · 2023 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)